Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Soft Tissue Sarcoma”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Testing effectiveness (Phase 2)Looking for participantsNCT03965234
What this trial is testing

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Who this might be right for
Metastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more
Roswell Park Cancer Institute 99
Testing effectiveness (Phase 2)Looking for participantsNCT06114225
What this trial is testing

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

Who this might be right for
Osteosarcoma
Ruijin Hospital 43
Testing effectiveness (Phase 2)UnknownNCT03063983
What this trial is testing

Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma

Who this might be right for
Osteosarcoma
Grupo de Apoio ao Adolescente e a Crianca com Cancer 158
Testing effectiveness (Phase 2)UnknownNCT00753727
What this trial is testing

Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Australasian Sarcoma Study Group 26
Testing effectiveness (Phase 2)Study completedNCT02300545
What this trial is testing

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

Who this might be right for
Sarcoma, Soft TissueSoft Tissue Sarcoma
Washington University School of Medicine 56
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Ended earlyNCT01048723
What this trial is testing

Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas

Who this might be right for
Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)WithdrawnNCT06116578
What this trial is testing

Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab

Who this might be right for
Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Large-scale testing (Phase 3)Study completedNCT00134030
What this trial is testing

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic Osteosarcoma
Children's Oncology Group 1,334
Early research (Phase 1)Study completedNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Not applicableUnknownNCT05739084
What this trial is testing

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS

Who this might be right for
Soft Tissue Sarcomas
Centre Leon Berard 300
Testing effectiveness (Phase 2)UnknownNCT04294511
What this trial is testing

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Who this might be right for
Osteosarcoma
Sun Yat-sen University 75
Not applicableLooking for participantsNCT04199026
What this trial is testing

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Who this might be right for
Metastatic SarcomaRecurrent SarcomaResectable Sarcoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)WithdrawnNCT00003273
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more
NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Early research (Phase 1)WithdrawnNCT03782363
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Italian Sarcoma Group
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT07049848
What this trial is testing

SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
M.D. Anderson Cancer Center 50
Early research (Phase 1)Ended earlyNCT01258634
What this trial is testing

Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

Who this might be right for
OsteosarcomaLung Metastases
University of Chicago 2
Early research (Phase 1)Study completedNCT04802070
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Prof. Franca Fagioli 7
Load More Results